biofir
filmarray
respiratori
panel
fa
rp
rapid
multiplex
molecular
assay
approv
detect
viral
atyp
bacteri
pathogen
nasopharyng
specimen
studi
aim
evalu
perform
biofir
filmarray
respiratori
panel
bronchoscopi
specimen
test
bronchial
specimen
archiv
prospect
collect
fa
rp
compar
result
luminex
nxtag
respiratori
pathogen
panel
nxtag
rpp
discord
analysi
specimen
gave
concord
result
use
fa
rp
nxtag
rpp
overal
agreement
kappa
ci
posit
percent
agreement
ci
neg
percent
agreement
ci
conclus
biofir
filmarray
rp
perform
reliabl
detect
broad
rang
respiratori
pathogen
bronchoscopi
specimen
respiratori
virus
caus
rang
clinic
syndrom
mild
selflimit
upper
respiratori
tract
urt
infect
complic
lower
respiratori
tract
lrt
infect
especi
patient
immunosuppress
andor
chronic
lung
diseas
chemali
et
al
garbino
et
al
kim
et
al
diagnosi
suspect
lrt
infect
immunocompromis
host
particularli
challeng
due
broad
rang
viral
bacteri
infecti
noninfecti
etiolog
present
similar
fashion
bajaj
tombach
rapid
detect
infecti
caus
lead
diagnost
clariti
target
time
therapi
implement
infect
control
practic
limit
transmiss
kim
et
al
recent
sever
molecular
diagnost
platform
panel
detect
extens
rang
respiratori
pathogen
introduc
hanson
couturi
ramanan
et
al
multiplex
assay
significantli
increas
diagnost
yield
ie
number
rang
organ
detect
detect
potenti
pathogen
routin
identifi
tradit
method
hanson
couturi
ko
drew
biofir
filmarray
respiratori
panel
fa
rp
one
fulli
autom
method
simultan
detect
respiratori
virus
bacteri
target
poritz
et
al
fa
rp
chosen
studi
comprehens
list
target
rapid
turnaround
time
eas
use
howev
fa
rp
current
approv
nasopharyng
np
specimen
limit
data
avail
perform
use
bronchoscopi
specimen
lrt
specimen
obtain
bronchoscopi
often
need
diagnos
suspect
lrt
infect
critic
ill
immunocompromis
patient
brownback
et
al
fa
rp
perform
bronchoscopi
specimen
shown
increas
diagnist
yield
patient
previous
test
neg
np
specimen
azadeh
et
al
lachant
et
al
aim
studi
evalu
abil
fa
rp
detect
respiratori
pathogen
bronchoscopi
specimen
bronchoalveolar
lavag
bal
bronchial
aspir
ba
bronchial
wash
bw
compar
respiratori
pathogen
detect
luminex
nxtag
respiratori
pathogen
panel
nxtag
rpp
studi
done
diagnost
microbiolog
laboratori
servic
acut
tertiari
care
center
vancouv
canada
includ
archiv
prospect
collect
bronchoscopi
specimen
archiv
posit
neg
conveni
specimen
includ
bal
bw
collect
decemb
novemb
initi
clinic
test
archiv
specimen
perform
time
diagnost
microbiolog
infecti
diseas
collect
refer
laboratori
bc
center
diseas
control
public
health
laboratori
use
nxtag
rpp
posit
archiv
specimen
studi
select
reflect
wide
rang
target
detect
fa
rp
test
fa
rp
archiv
specimen
done
septemb
februari
archiv
bw
posit
mycoplasma
pneumonia
pneumonia
initi
test
refer
laboratori
use
lab
develop
multiplex
pcr
ld
pcr
pneumonia
legionella
pneumophila
l
pneumophila
chlamydophila
pneumonia
c
pneumonia
base
protocol
welti
et
al
welti
et
al
specimen
subsequ
test
fa
rp
nxtag
rpp
prospect
collect
bronchoscopi
specimen
bal
ba
collect
decemb
may
specimen
randomli
select
patient
suspect
acut
respiratori
tract
infect
specif
hospit
locat
chosen
typic
hous
immunocompromis
patient
patient
underli
chronic
lung
diseas
bone
marrow
transplant
unit
respiratorythorac
unit
intens
care
unit
prospect
collect
specimen
test
parallel
use
fa
rp
clinic
laboratori
nxtag
rpp
refer
laboratori
archiv
specimen
store
long
term
storag
prospect
collect
specimen
kept
storag
less
one
week
biofir
fa
rp
version
biomerieux
stlaurent
canada
detect
follow
viral
bacteri
pathogen
adenoviru
adv
human
coronaviru
hcov
influenza
inf
subtyp
influenza
b
inf
b
human
metapneumoviru
hmpv
parainfluenza
viru
piv
type
type
type
type
respiratori
syncyti
viru
rsv
rhinovirusenteroviru
hrvev
bordetella
pertussi
b
pertussi
c
pneumonia
pneumonia
assay
perform
accord
manufactur
instruct
test
perform
neat
undilut
bronchoscopi
specimen
without
pretreat
mucoid
specimen
briefli
sampl
mix
sampl
buffer
inject
test
pouch
contain
necessari
reagent
nucleic
extract
pcr
amplif
detect
respect
target
test
pouch
insert
biofir
filmarray
instrument
run
use
provid
softwar
luminex
nxtag
rpp
luminex
molecular
diagnost
toronto
canada
detect
follow
viral
bacteri
pathogen
adv
human
bocaviru
bov
hcov
inf
viru
subtyp
inf
b
viru
hmpv
piv
type
rsv
type
b
hrvev
l
pneumophila
c
pneumonia
pneumonia
test
perform
refer
laboratori
previous
valid
use
bronchoscopi
specimen
jassem
et
al
nucleic
acid
extract
perform
specimen
magmax
deep
well
magnet
particl
processor
use
viral
rna
isol
kit
thermo
fisher
scientif
waltham
accord
manufactur
instruct
nucleic
acid
amplifi
hybrid
eppendorf
mastercycl
pro
pcr
system
fisher
scientif
waltham
thermocycl
condit
set
manufactur
data
acquisit
perform
magpix
instrument
accord
manufactur
instruct
assess
detect
b
pertussi
spike
specimen
gener
bal
previous
test
neg
target
fa
rp
pool
mcfarland
standard
suspens
b
pertussi
clinic
isol
dilut
pool
neg
bal
concentr
cfumlth
detect
limit
fa
rp
target
given
manufactur
fa
rp
version
packag
insert
fa
rp
test
perform
describ
use
dilut
suspens
fa
rp
result
agreement
initi
nxtag
rpp
test
done
fa
rp
initi
nxtag
rpp
result
discord
repeat
nxtag
rpp
test
done
discord
pneumonia
result
retest
ld
pcr
pneumonia
l
pneumophila
c
pneumonia
describ
consensu
defin
minimum
result
agreement
fa
rp
initi
nxtag
rpp
repeat
nxtag
rppld
pcr
posit
percent
agreement
ppa
neg
percent
agreement
npa
confid
interv
ci
calcul
use
softwar
http
overal
agreement
fa
rp
assay
either
nxtag
rpp
consensu
result
measur
kappa
statist
http
wwwgraphpadcomquickcalc
differ
test
perform
assess
use
mcnemar
p
valu
http
wwwgraphpadcomquickcalc
websit
access
februari
total
archiv
specimen
bal
n
bw
n
adult
patient
select
initi
evalu
fa
rp
specimen
patient
mean
age
standard
deviat
sd
age
unknown
patient
follow
hospit
locat
outpati
bronchoscopi
suit
n
intens
care
unit
n
respiratorythorac
unit
n
respiratori
ambulatori
unit
n
bone
marrow
transplant
unit
n
medicin
unit
n
tuberculosi
unit
n
preadmit
center
n
unknown
n
major
specimen
n
initi
test
nxtag
rpp
subsequ
fa
rp
four
pneumonia
posit
bw
initi
test
ld
pcr
detect
pneumonia
l
pneumophila
c
pneumonia
test
fa
rp
nxtag
rpp
studi
archiv
specimen
specimen
one
target
detect
either
method
specimen
target
detect
either
method
one
specimen
target
detect
one
method
nxtag
rpp
one
pneumonia
posit
bw
mucoid
repeatedli
fail
test
fa
rp
specimen
exclud
analysi
leav
archiv
specimen
concord
result
fa
rp
nxtag
rpp
obtain
specimen
result
overal
agreement
kappa
ci
concord
posit
concord
neg
result
detect
thirtyeight
specimen
test
posit
pathogen
fa
rp
nxtag
rpp
hcov
n
hcov
n
hcov
n
hcov
n
inf
n
inf
b
n
piv
n
piv
n
piv
n
hrvev
n
rsv
n
pneumonia
n
specimen
pathogen
rsv
hrv
ev
hcov
hrvev
hrvev
piv
detect
method
influenza
observ
concord
posit
specimen
inf
one
specimen
posit
inf
without
subtyp
fa
rp
posit
inf
nxtag
rpp
consid
concord
result
discord
result
obtain
specimen
tabl
one
nxtag
rpp
detect
bov
human
hrvev
fa
rp
result
neg
sinc
bov
fa
rp
target
result
disregard
hrvev
result
consid
discord
specimen
discord
viral
target
retest
nxtag
rpp
determin
degrad
analyt
occur
storag
archiv
sampl
would
account
discord
result
detail
discord
analysi
provid
tabl
one
specimen
discord
piv
fa
rp
neg
nxtag
rpp
posit
could
repeat
due
insuffici
sampl
exclud
analysi
leav
archiv
sampl
analysi
resolut
discord
result
archiv
specimen
overal
ppa
npa
ci
ci
respect
tabl
perfect
kappa
good
agreement
kappa
found
detect
target
except
hrvev
inf
agreement
test
hrvev
kappa
inf
kappa
consid
good
total
prospect
collect
specimen
obtain
adult
patient
mean
age
sd
follow
hospit
unit
intens
care
unit
n
respiratorythorac
unit
n
bone
marrow
transplant
unit
n
includ
bal
ba
test
fa
rp
lmx
nxtag
rpp
parallel
result
test
method
concord
sampl
overal
agreement
kappa
ci
specimen
concord
posit
one
viral
pathogen
adv
n
hmpv
n
rsv
n
hcov
n
hcov
n
hrvev
n
inf
n
sampl
test
neg
method
coinfect
observ
group
three
discord
adv
result
note
tabl
two
specimen
collect
patient
day
apart
repeat
nxtag
rpp
discord
analysi
specimen
consid
posit
adv
prospect
collect
specimen
posit
neg
percent
agreement
fa
rp
nxtag
rpp
kappa
target
detect
except
adv
fa
rp
fail
detect
adv
posit
specimen
result
ppa
npa
adv
ci
ci
respect
posit
rate
prospect
collect
specimen
archiv
n
prospect
collect
n
studi
specimen
combin
initi
agreement
platform
kappa
ci
discord
analysi
concord
fa
rp
nx
tag
rpp
demonstr
includ
specimen
result
overal
agreement
kappa
ci
total
fa
rp
result
confirm
specimen
discord
analysi
consid
fals
posit
consid
fals
neg
tabl
ppa
npa
target
archiv
prospect
collect
specimen
combin
ci
ci
respect
tabl
overal
signific
differ
perform
fa
rp
nxtag
rpp
mcnemar
p
singl
target
ppa
target
detect
tabl
greatest
variabl
observ
hrvev
inf
discord
result
respect
note
discord
analysi
b
pertussi
includ
nxtag
rpp
posit
clinic
specimen
avail
contriv
posit
specimen
test
fa
rp
sampl
spike
b
pertussi
isol
limit
detect
test
posit
organ
data
shown
c
pneumonia
clinic
specimen
isol
avail
diagnost
perform
target
could
evalu
result
studi
demonstr
biofir
fa
rp
reliabl
detect
broad
rang
respiratori
pathogen
perform
use
specimen
collect
bronchoscopi
thu
far
major
studi
evalu
perform
fa
rp
done
use
np
swab
andersson
et
al
babadi
et
al
butt
et
al
hayden
et
al
kaku
et
al
loeffelholz
et
al
pierc
et
al
renaud
et
al
van
wesenbeeck
et
al
studi
includ
lrt
specimen
bal
ba
addit
urt
sampl
azadeh
et
al
found
test
bal
specimen
fa
rp
increas
diagnost
yield
immunocompromis
patient
initi
neg
np
swab
azadeh
et
al
addit
determin
limit
detect
lod
fa
rp
lrt
specimen
either
lower
similar
lod
np
swab
target
ruggiero
et
al
howev
studi
done
archiv
sampl
limit
small
number
lrt
sampl
includ
low
coverag
fa
rp
target
clinic
sampl
test
knowledg
largest
studi
date
investig
perform
fa
rp
archiv
prospect
collect
bronchoscopi
specimen
found
high
posit
rate
prospect
collect
bronchoscopi
specimen
immunocompromis
hospit
patient
influenza
season
find
consist
studi
azadeh
et
al
similarli
high
posit
rate
note
fa
rp
test
bal
immunocompromis
host
azadeh
et
al
azadeh
et
al
syndrom
molecular
test
increas
sensit
detect
respiratori
pathogen
test
distinguish
colon
infect
patient
therefor
import
perform
test
patient
appropri
clinic
indic
furthermor
result
need
interpret
caution
immunosuppress
patient
prolong
shed
known
occur
charlton
et
al
studi
show
good
agreement
biofir
fa
rp
luminex
nxtag
rpp
detect
respiratori
pathogen
bronchoscopi
specimen
studi
confirm
high
agreement
fa
rp
variou
version
luminex
respiratori
panel
np
swab
chan
et
al
chen
et
al
popowitch
et
al
tang
et
al
studi
includ
np
swab
limit
number
bw
bal
found
fa
rp
detect
virus
luminex
method
babadi
et
al
rand
et
al
mention
differ
test
perform
bal
np
swab
studi
signific
differ
number
virus
detect
either
system
knowledg
direct
comparison
fa
rp
nxtag
rpp
done
lower
respiratori
specimen
perform
fa
rp
archiv
prospect
specimen
overal
similar
although
higher
number
discord
result
note
archiv
specimen
result
slightli
decreas
npa
compar
prospect
studi
specimen
possibl
effect
prolong
sampl
storag
multipl
freezethaw
cycl
murphi
bustin
shao
et
al
greatest
number
discord
result
note
adv
hrvev
inf
target
possibl
explan
discord
result
low
viral
load
sampl
degrad
result
prolong
storag
reagent
competit
specimen
multipl
target
detect
unfortun
quantit
indic
provid
assess
platform
consequ
difficult
determin
target
concentr
sampl
hammond
et
al
found
higher
number
specimen
posit
hrvev
fa
rp
compar
direct
fluoresc
antibodi
test
real
time
pcr
author
attribut
low
analyt
concentr
sampl
slightli
higher
sensit
fa
rp
assay
hammond
et
al
previou
studi
shown
decreas
sensit
adv
detect
fa
rp
couturi
et
al
pierc
et
al
popowitch
et
al
couturi
et
al
note
lod
fa
rp
compar
lab
develop
test
much
higher
log
differ
adv
viral
target
couturi
et
al
howev
studi
use
earlier
version
fa
rp
decreas
sensit
adv
due
limit
coverag
adv
serotyp
filmarray
v
packag
insert
fa
rp
assay
sinc
revis
modifi
fa
rp
version
demonstr
increas
sensit
adv
improv
adv
serotyp
coverag
andersson
et
al
doern
et
al
updat
fa
rp
version
use
studi
observ
signific
differ
perform
adv
multiplex
assay
adv
result
remain
discord
consid
fals
neg
fa
rp
note
discord
result
inf
overal
perform
fa
rp
influenza
good
agreement
nxtag
rpp
due
low
number
variou
influenza
subtyp
difficult
draw
conclus
influenza
subtyp
perform
limit
studi
includ
low
number
posit
sampl
pathogen
detect
fa
rp
use
archiv
specimen
possibl
loss
target
prolong
storag
fa
rp
result
evalu
nxtag
rpp
consensu
method
thu
observ
perform
characterist
fa
rp
might
bias
favor
nxtag
rpp
limit
associ
select
archiv
specimen
prospect
collect
specimen
includ
studi
mitig
effect
furthermor
fa
rp
provid
qualit
detect
target
presenc
discord
analysi
limit
lack
quantit
inform
due
unavail
true
gold
standard
result
studi
reflect
agreement
multiplex
platform
ideal
result
fa
rp
would
compar
singleplex
pcr
target
summari
biofir
fa
rp
reliabl
detect
respiratori
pathogen
bronchoscopi
specimen
use
fa
rp
test
bronchoscopi
specimen
hospit
set
enabl
complet
approach
diagnosi
lrt
infect
vulner
patient
